$CTXR

Citius Pharmaceuticals Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Medicinal and Botanical Manufacturing

PRICE

$0.9058 ▲1.309%

Last Close

VOLUME

849,780

DAY RANGE

0.8906 - 0.939

52 WEEK

0.8306 - 2.47

Join Discuss about CTXR with like-minded investors

profile
@dros #droscrew
recently

Largest borrow rate increases among liquid names $ELMS $GOEV $CCIV $OWL $XELA $CL $ZEV $CPNG $GT $CTXR

65 Replies 11 👍 13 🔥

profile
@dros #droscrew
recently

Largest borrow rate increases among liquid names $ELMS $GOEV $CCIV $OWL $XELA $CL $ZEV $CPNG $GT $CTXR

115 Replies 15 👍 14 🔥

profile
@CarlosH-carvan #ivtrades
recently

$CTXR low float

142 Replies 7 👍 11 🔥

Key Metrics

Market Cap

130.65 M

Beta

1.22

Avg. Volume

1.70 M

Shares Outstanding

146.13 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.

CEO: Myron Holubiak

Website:

HQ: 11 Commerce Dr Fl 1 Cranford, 07016-3501 New Jersey

Related News